IFPMA
7 data points extracted from 1 publication by this organisation.
Data points
7
Documents
1
Indicators
7
Regions
1
Publisher type
Industry association
Bibliography
Documents used
Every publication we have taken a number from, with the date we read it and the link status at that time.
| Document | Type | Published | Retrieved | Link | Data points |
|---|---|---|---|---|---|
| Enabling innovation: The R&D ecosystem for medicines and vaccines Licence: See source | Press release | — | 15 Sep 2026 | Reachable | 7 |
Every figure
Data points
Every figure taken from this organisation, grouped by indicator.
| Indicator | Region | Period | Value | Type | Full record |
|---|---|---|---|---|---|
| Medicines in clinical development | Global | 2025 | 12,900 | actual | → |
| Novel active substance launches | Global | 2004–2023 | 942 | actual | → |
| Pharmaceutical industry direct employment | Global | 2022 | 7.8 million | actual | → |
| Pharmaceutical R&D employment | Global | 2022 | 1 million | actual | → |
| Pharmaceutical R&D GDP contribution | Global | 2022 | 227 billion USD | actual | → |
| R&D share of pharmaceutical direct economic contribution | Global | 2022 | 30% | actual | → |
| Share of clinical development medicines dedicated to non-communicable diseases | Global | 2025 | 75% | actual | → |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. Credit IFPMA as the original publisher; each record page carries its own citation.
IFPMA. Retrieved from StatOrigin: https://statorigin.org/sources/ifpma
Keep exploring
Related
Industries using this source
Last verified 17 September 2026. Link status is rechecked weekly.